Background/Aims: Despite several reports on clinical aspects of anemia and malignancy, little is known of male patients with iron-deficiency anemia (IDA) and malignancy in Korea. We examined the cause of anemia, prevalence of and factors associated with malignancy, and treatment response to iron therapy in male IDA patients.
. In this study, a response was defined as an increase in the ferritin level to 40 ng/mL and in the hemoglobin to 13 g/dL after 9-12 months or 18 months of oral iron therapy.
b
In this study, a response was defined as an increase in the hemoglobin level to 13 g/dL regardless of the ferritin level after oral iron therapy. 
